Case Study
Unlocking Novel Targets to Treat Neuroscience Diseases at Cerevel Therapeutics
This case study describes how Cerevel Therapeutics approached the challenge of unlocking novel targets to treat complex neuroscience diseases. With ambitious research goals, Cerevel recognized early that its success depended on selecting the right software partner. The company formed a cross-functional evaluation team to find a solution that could support sophisticated research workflows, enable a single cloud-based platform for data warehousing and analytics, foster cross-functional collaboration, protect intellectual property through strong security, and scale with the organization’s growth. By investing time in thorough due diligence, Cerevel aimed to build a robust, future-ready digital foundation capable of accelerating discovery, improving data-driven decision-making, and supporting
